Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression
- PMID: 19061981
- DOI: 10.1016/j.bone.2008.10.050
Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression
Abstract
Three patients with neurofibromatosis 1 (NF1) were operated for congenital pseudarthrosis (PA) of the tibia. Three non-NF1 patients served as reference. Both NF1 mRNA and protein were detected in the PAs and in rows of osteoblasts and numerous osteoclasts next to the NF1-related PA arguing against inactivation of both NF1 alleles in the resident cells. Analyses on mesenchymal stem cells (MSCs) cultured from the red bone marrow of 1) next to PA of the affected NF1 tibiae, 2) the non-affected NF1 iliac crest of the same patients, and from 3) non-NF1 bone marrow demonstrated that the potential to form bone in vitro was the lowest in cells from the affected NF1-tibiae. The latter cells also displayed reduced levels of NF1 mRNA and protein, and upregulated phosphorylated p44/42 MAPK levels, consistent with an upregulated Ras-pathway. An exhaustive NF1 gene analysis detected constitutional mutation in each case, but no second hits or loss of heterozygosity were found. However, one patient displayed a mutation resulting in two potential active splice sites ultimately affecting exon 6. Interestingly, only one of the respective transcripts was detected in cells from the iliac crest, but two novel transcripts were detected in MSCs cultured from site next to PA. This finding may identify a novel mechanism how a single NF1 gene mutation may exert distinct effects on separate anatomical locations. The molecular pathogenesis of NF1-related PA apparently may not be entirely explained by second mutations or loss of heterozygosity of the NF1 gene.
Similar articles
-
Vasculopathy in two cases of NF1-related congenital pseudarthrosis.Pathol Res Pract. 2006;202(9):687-90. doi: 10.1016/j.prp.2006.03.006. Epub 2006 Jun 2. Pathol Res Pract. 2006. PMID: 16735097
-
A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.J Bone Miner Res. 2012 Jan;27(1):68-78. doi: 10.1002/jbmr.528. J Bone Miner Res. 2012. PMID: 21956219
-
Neurofibromatosis type 1-related pseudarthrosis: Beyond the pseudarthrosis site.Hum Mutat. 2019 Oct;40(10):1760-1767. doi: 10.1002/humu.23783. Epub 2019 Jun 18. Hum Mutat. 2019. PMID: 31066482
-
Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1).Bone. 2008 Apr;42(4):616-22. doi: 10.1016/j.bone.2007.11.006. Epub 2007 Nov 28. Bone. 2008. PMID: 18248783 Review.
-
Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.Dev Period Med. 2014 Jul-Sep;18(3):297-306. Dev Period Med. 2014. PMID: 25182393 Review.
Cited by
-
Genetic Analyses of the NF1 Gene in Turkish Neurofibromatosis Type I Patients and Definition of three Novel Variants.Balkan J Med Genet. 2017 Jun 30;20(1):13-20. doi: 10.1515/bjmg-2017-0008. eCollection 2017 Jun 30. Balkan J Med Genet. 2017. PMID: 28924536 Free PMC article.
-
Serum-derived exosomes from neurofibromatosis type 1 congenital tibial pseudarthrosis impaired bone by promoting osteoclastogenesis and inhibiting osteogenesis.Exp Biol Med (Maywood). 2021 Jan;246(2):130-141. doi: 10.1177/1535370220962737. Epub 2020 Oct 6. Exp Biol Med (Maywood). 2021. PMID: 33023333 Free PMC article.
-
Combined technique with hydroxyapatite coated intramedullary nails in treatment of anterolateral bowing of congenital pseudarthrosis of tibia.J Orthop. 2019 Nov 12;19:189-193. doi: 10.1016/j.jor.2019.11.017. eCollection 2020 May-Jun. J Orthop. 2019. PMID: 32025131 Free PMC article.
-
Disturbed osteoblastic differentiation of fibrous hamartoma cell from congenital pseudarthrosis of the tibia associated with neurofibromatosis type I.Clin Orthop Surg. 2011 Sep;3(3):230-7. doi: 10.4055/cios.2011.3.3.230. Epub 2011 Aug 19. Clin Orthop Surg. 2011. PMID: 21909471 Free PMC article.
-
Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.J Bone Miner Res. 2015 Jan;30(1):55-63. doi: 10.1002/jbmr.2316. J Bone Miner Res. 2015. PMID: 25043591 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous